1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SPRINGWORKS THERAPEUTICS INC
SpringWorks Therapeutics Inc XNAS: SWTX
Momentum Trap

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for SpringWorks Therapeutics Inc is on 07 Aug 2025 for the purpose of SpringWorks Therapeutics Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for SpringWorks Therapeutics Inc

The latest disclosure was made by Lynch Daniel S. in SpringWorks Therapeutics Inc where a trade of 7,464 Stock Option (Right to Buy) done was reported to US exchanges on July 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lynch Daniel S. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 7,464 0 - - Stock Option (Right to Buy)
P. Nofi Michael Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 65,000 0 - - Stock Option (Right to Buy)
Weinstein S. Herschel General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,157 0 - - Performance Share Units
Martin Mackay W. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 20,023 0 (0%) 0% - Common Stock
Francis I. Perier Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 60,889 0 (0%) 0% - Common Stock
Lewis-Hall Freda C. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 24,727 0 (0%) 0% - Common Stock
Edris Badreddin Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 100,000 0 - - Stock Option (Right to Buy)
I. Francis Perier Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 75,000 0 - - Stock Option (Right to Buy)
C. Lewis-Hall Freda Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,318 0 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 33,778 0 - - Performance Share Units
Julie Hambleton Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 14,155 0 (0%) 0% - Common Stock
Nofi Michael P. Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 8,661 0 - - Performance Share Units
Islam Saqib Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 260,000 0 - - Stock Option (Right to Buy)
Weinstein Herschel S. General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 55,239 0 (0%) 0% - Common Stock
Saqib Islam Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 109,329 0 - - Stock Option (Right to Buy)
Pichl Daniel Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 50,762 0 (0%) 0% - Common Stock
Pichl Daniel Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 64,000 0 - - Stock Option (Right to Buy)
Weinstein Herschel S. General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 106,600 0 - - Stock Option (Right to Buy)
Perier Francis I. Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 368,923 0 - - Stock Option (Right to Buy)
Islam Saqib Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 954,869 0 (0%) 2% - Common Stock
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 169,712 0 (0%) 0% - Common Stock
Islam Saqib Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 579,749 0 - - Performance Share Units
Bhavesh Ashar Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 62,053 0 (0%) 0% - Common Stock
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 240,000 0 - - Stock Option (Right to Buy)
Martin Mackay W. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 29,445 0 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 37,455 0 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 21,654 0 - - Performance Share Units
James Cassidy Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 81,731 0 (0%) 0% - Common Stock
Ashar Bhavesh Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 75,000 0 - - Stock Option (Right to Buy)
Alan Fuhrman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 24,727 0 (0%) 0% - Common Stock
Francis I. Perier Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 34,419 0 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 72,680 0 - - Stock Option (Right to Buy)
Daniel S. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 13,774 0 - - Stock Option (Right to Buy)
Alan Fuhrman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 12,216 0 - - Stock Option (Right to Buy)
Francis I. Perier Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 60,000 0 - - Stock Option (Right to Buy)
Alban Carlos Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 12,216 0 - - Stock Option (Right to Buy)
Hambleton Julie Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 14,668 0 - - Stock Option (Right to Buy)
C. Freda Lewis-Hall Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 29,983 0 - - Stock Option (Right to Buy)
Hambleton Julie Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,318 0 - - Stock Option (Right to Buy)
Lin Tai-An Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,000 0 - - Stock Option (Right to Buy)
Lin Tai-An Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 75,000 0 - - Stock Option (Right to Buy)
S. Daniel Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,318 0 - - Stock Option (Right to Buy)
Lin Tai-An Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 8,661 0 - - Performance Share Units
Julie Hambleton Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 12,216 0 - - Stock Option (Right to Buy)
Edris Badreddin Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 78,960 0 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 149,470 0 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 3,868 0 - - Stock Option (Right to Buy)
Lewis-Hall C. Freda Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 12,216 0 - - Stock Option (Right to Buy)
S. Herschel Weinstein General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 125,000 0 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 100,000 0 - - Stock Option (Right to Buy)
Carlos Alban Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 30,160 0 - - Stock Option (Right to Buy)
Lin Tai-An Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 33,039 0 (0%) 0% - Common Stock
Alan Fuhrman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 13,774 0 - - Stock Option (Right to Buy)
Fuhrman Alan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 29,983 0 - - Stock Option (Right to Buy)
Lynch Daniel S. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 6,447 0 - - Stock Option (Right to Buy)
Perier Francis I. Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 125,000 0 - - Stock Option (Right to Buy)
Michael Nofi P. Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 20,246 0 - - Stock Option (Right to Buy)
Cassidy James Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 80,000 0 - - Stock Option (Right to Buy)
Lynch S. Daniel Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 93,004 0 (0%) 0% - Common Stock
Fuhrman Alan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 7,464 0 - - Stock Option (Right to Buy)
Cassidy James Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 135,000 0 - - Stock Option (Right to Buy)
Daniel Lynch S. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 12,216 0 - - Stock Option (Right to Buy)
Carlos Alban Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 13,774 0 - - Stock Option (Right to Buy)
S. Herschel Weinstein General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 60,000 0 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 70,000 0 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 16,023 0 - - Performance Share Units
S. Herschel Weinstein General Counsel & Secretary Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 35,431 0 - - Stock Option (Right to Buy)
Lynch Daniel S. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 29,983 0 - - Stock Option (Right to Buy)
Tai-An Lin Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 20,246 0 - - Stock Option (Right to Buy)
Fuhrman Alan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 15,318 0 - - Stock Option (Right to Buy)
Alban Carlos Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 28,861 0 (0%) 0% - Common Stock
Pichl Daniel Chief People Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 65,000 0 - - Stock Option (Right to Buy)
C. Freda Lewis-Hall Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 7,464 0 - - Stock Option (Right to Buy)
Lynch Daniel S. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 232,376 0 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 176,411 0 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 325,000 0 - - Stock Option (Right to Buy)
I. Perier Francis Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 14,724 0 - - Performance Share Units
Cassidy James Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 21,654 0 - - Performance Share Units
Nofi Michael P. Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 30,623 0 (0%) 0% - Common Stock
Cassidy James Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 50,615 0 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 250,000 0 - - Stock Option (Right to Buy)
Nofi Michael P. Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 78,300 0 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 120,000 0 - - Stock Option (Right to Buy)
Lewis-Hall Freda C. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 13,774 0 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 22,760 0 - - Stock Option (Right to Buy)
Islam Saqib Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 769,804 0 - - Stock Option (Right to Buy)
Ashar Bhavesh Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 50,615 0 - - Stock Option (Right to Buy)
P. Michael Nofi Chief Accounting Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 01 Jul 2025 40,000 0 - - Stock Option (Right to Buy)
Martin W. Mackay Director 14 May 2025 10,060 20,023 (0%) 0% 0 Common Stock
Freda C. Lewis-Hall Director 14 May 2025 10,060 24,727 (0%) 0% 0 Common Stock
Alan Fuhrman Director 14 May 2025 10,060 24,727 (0%) 0% 0 Common Stock
Carlos Alban Director 14 May 2025 10,060 28,861 (0%) 0% 0 Common Stock
Daniel S. Lynch Director 14 May 2025 10,060 93,004 (0%) 0% 0 Common Stock
Julie Hambleton Director 14 May 2025 10,060 14,155 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 03 Mar 2025 3,598 170,112 (0%) 0% 55.1 198,331 Common Stock
Badreddin Edris Chief Operating Officer 03 Mar 2025 12,078 173,710 (0%) 0% 54.3 655,331 Common Stock
Badreddin Edris Chief Operating Officer 03 Mar 2025 3,924 185,788 (0%) 0% 53.1 208,450 Common Stock
Badreddin Edris Chief Operating Officer 03 Mar 2025 400 169,712 (0%) 0% 56.2 22,481 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 23,600 968,469 (2%) 0% 54.2 1,280,135 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 30,756 1,003,869 (2%) 0% 53.4 1,642,678 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 11,800 992,069 (2%) 0% 53.0 625,017 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 600 954,869 (2%) 0% 56.9 34,134 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 1,400 955,469 (2%) 0% 56.1 78,588 Common Stock
Saqib Islam Director, Chief Executive Officer 27 Feb 2025 11,600 956,869 (2%) 0% 55.2 639,783 Common Stock
Saqib Islam Director, Chief Executive Officer 20 Feb 2025 24,260 1,039,693 (2%) 0% 60.1 1,458,053 Common Stock
Saqib Islam Director, Chief Executive Officer 20 Feb 2025 5,068 1,034,625 (2%) 0% 61.2 310,348 Common Stock
Daniel S. Lynch Director 20 Feb 2025 3,582 82,944 (0%) 0% 61.2 219,349 Common Stock
Daniel S. Lynch Director 20 Feb 2025 44,018 86,526 (0%) 0% 60.1 2,647,185 Common Stock
Bhavesh Ashar Chief Commercial Officer 20 Feb 2025 1,016 62,053 (0%) 0% 61.2 62,168 Common Stock
Saqib Islam Director, Chief Executive Officer 14 Feb 2025 10,672 1,063,953 (2%) 0% 59.9 639,490 Common Stock
Daniel S. Lynch Director 14 Feb 2025 400 130,544 (0%) 0% 60 24,000 Common Stock
Saqib Islam Director, Chief Executive Officer 12 Feb 2025 13,186 1,074,625 (2%) 0% 59.3 781,666 Common Stock
Saqib Islam Director, Chief Executive Officer 12 Feb 2025 85,309 1,087,811 (2%) 0% 0 Common Stock
Saqib Islam Director, Chief Executive Officer 10 Feb 2025 48,000 1,002,502 (2%) 0% 53.3 2,558,237 Common Stock
Daniel S. Lynch Director 10 Feb 2025 65,600 130,944 (0%) 0% 55.5 3,641,751 Common Stock
Daniel S. Lynch Director 10 Feb 2025 39,634 196,544 (0%) 0% 54.9 2,175,047 Common Stock
Daniel S. Lynch Director 10 Feb 2025 69,766 236,178 (0%) 0% 53.2 3,713,553 Common Stock
Julie Hambleton Director 10 Feb 2025 13,774 17,869 (0%) 0% 32.3 444,487 Common Stock
Julie Hambleton Director 10 Feb 2025 13,774 0 - - Stock Option (Right to Buy)
Julie Hambleton Director 10 Feb 2025 13,774 4,095 (0%) 0% 53.0 730,207 Common Stock
Badreddin Edris Chief Operating Officer 10 Feb 2025 30,000 189,712 (0%) 0% 53.1 1,593,795 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 7,000 50,762 (0%) 0% 57.2 400,072 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 9,000 57,762 (0%) 0% 54.3 488,260 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 13,750 66,762 (0%) 0% 53.0 728,998 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 16,000 80,512 (0%) 0% 27.6 442,240 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 13,750 64,512 (0%) 0% 27.6 380,050 Common Stock
Daniel Pichl Chief People Officer 10 Feb 2025 13,750 31,250 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 10 Feb 2025 16,000 32,750 - - Stock Option (Right to Buy)
Herschel S. Weinstein General Counsel & Secretary 10 Jan 2025 12,126 55,239 (0%) 0% 0 Common Stock
Herschel S. Weinstein General Counsel & Secretary 10 Jan 2025 35,431 35,431 - - Stock Option (Right to Buy)
Francis I. Perier Chief Financial Officer 10 Jan 2025 11,779 60,889 (0%) 0% 0 Common Stock
Francis I. Perier Chief Financial Officer 10 Jan 2025 34,419 34,419 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer 10 Jan 2025 109,329 109,329 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer 10 Jan 2025 74,834 1,050,502 (2%) 0% 0 Common Stock
Michael Nofi P. Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 20,246 20,246 - - Stock Option (Right to Buy)
Michael Nofi P. Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 6,929 30,623 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 10 Jan 2025 27,023 219,712 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 10 Jan 2025 78,960 78,960 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 10 Jan 2025 37,455 37,455 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 10 Jan 2025 12,819 50,762 (0%) 0% 0 Common Stock
Bhavesh Ashar Chief Commercial Officer 10 Jan 2025 50,615 50,615 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 10 Jan 2025 17,323 63,069 (0%) 0% 0 Common Stock
James Cassidy Chief Medical Officer 10 Jan 2025 17,323 81,731 (0%) 0% 0 Common Stock
James Cassidy Chief Medical Officer 10 Jan 2025 50,615 50,615 - - Stock Option (Right to Buy)
Tai-An Lin Chief Scientific Officer 10 Jan 2025 20,246 20,246 - - Stock Option (Right to Buy)
Tai-An Lin Chief Scientific Officer 10 Jan 2025 6,929 33,039 (0%) 0% 0 Common Stock
Herschel S. Weinstein General Counsel & Secretary 04 Jan 2025 3,575 48,664 (0%) 0% 38.2 136,529 Common Stock
Herschel S. Weinstein General Counsel & Secretary 04 Jan 2025 3,272 45,392 (0%) 0% 38.2 124,958 Common Stock
Herschel S. Weinstein General Counsel & Secretary 04 Jan 2025 2,279 43,113 (0%) 0% 38.9 88,562 Common Stock
Francis I. Perier Chief Financial Officer 04 Jan 2025 3,283 49,110 (0%) 0% 38.9 127,577 Common Stock
Francis I. Perier Chief Financial Officer 04 Jan 2025 3,582 55,671 (0%) 0% 38.2 136,797 Common Stock
Francis I. Perier Chief Financial Officer 04 Jan 2025 3,278 52,393 (0%) 0% 38.2 125,187 Common Stock
Saqib Islam Director, Chief Executive Officer 04 Jan 2025 13,469 1,000,899 (2%) 0% 38.2 514,381 Common Stock
Saqib Islam Director, Chief Executive Officer 04 Jan 2025 12,872 988,027 (2%) 0% 38.2 491,582 Common Stock
Saqib Islam Director, Chief Executive Officer 04 Jan 2025 12,359 975,668 (2%) 0% 38.9 480,271 Common Stock
Michael Nofi P. Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.86 per share. 04 Jan 2025 1,009 23,694 (0%) 0% 38.9 39,210 Common Stock
Michael Nofi P. Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. 04 Jan 2025 1,636 24,703 (0%) 0% 38.2 62,479 Common Stock
Michael Nofi P. Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. 04 Jan 2025 2,388 26,339 (0%) 0% 38.2 91,198 Common Stock
Badreddin Edris Chief Operating Officer 04 Jan 2025 5,561 197,105 (0%) 0% 38.2 212,375 Common Stock
Badreddin Edris Chief Operating Officer 04 Jan 2025 6,934 202,666 (0%) 0% 38.2 264,809 Common Stock
Badreddin Edris Chief Operating Officer 04 Jan 2025 4,416 192,689 (0%) 0% 38.9 171,606 Common Stock
Daniel Pichl Chief People Officer 04 Jan 2025 1,759 37,943 (0%) 0% 38.9 68,355 Common Stock
Daniel Pichl Chief People Officer 04 Jan 2025 2,988 42,224 (0%) 0% 38.2 114,112 Common Stock
Daniel Pichl Chief People Officer 04 Jan 2025 2,522 39,702 (0%) 0% 38.2 96,315 Common Stock
Bhavesh Ashar Chief Commercial Officer 04 Jan 2025 2,284 45,746 (0%) 0% 38.9 88,756 Common Stock
Bhavesh Ashar Chief Commercial Officer 04 Jan 2025 4,475 51,855 (0%) 0% 38.2 170,900 Common Stock
Bhavesh Ashar Chief Commercial Officer 04 Jan 2025 3,825 48,030 (0%) 0% 38.2 146,077 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2025 4,325 69,531 (0%) 0% 38.2 165,172 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2025 1,658 64,408 (0%) 0% 38.9 64,430 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2025 3,465 66,066 (0%) 0% 38.2 132,328 Common Stock
Tai-An Lin Chief Scientific Officer 04 Jan 2025 855 26,110 (0%) 0% 38.2 32,652 Common Stock
Badreddin Edris Chief Operating Officer 03 Dec 2024 11,966 217,634 (0%) 0% 41.8 499,942 Common Stock
Edris Badreddin Chief Operating Officer 03 Dec 2024 8,034 209,600 (0%) 0% 42.2 339,394 Common Stock
Saqib Islam Director, Chief Executive Officer 02 Dec 2024 3,989 1,014,368 (2%) 0% 41.8 166,936 Common Stock
Saqib Islam Director, Chief Executive Officer 02 Dec 2024 45,011 1,018,357 (2%) 0% 41.3 1,860,422 Common Stock
Tai-An Lin Chief Scientific Officer 02 Oct 2024 2,324 26,965 (0%) 0% 32.8 76,297 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Sep 2024 32,400 1,079,968 (2%) 0% 40.1 1,299,224 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Sep 2024 6,692 1,063,368 (2%) 0% 42.1 281,550 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Sep 2024 9,908 1,070,060 (2%) 0% 41.1 407,259 Common Stock
Badreddin Edris Chief Operating Officer 03 Sep 2024 4,620 232,680 (0%) 0% 41.1 189,955 Common Stock
Badreddin Edris Chief Operating Officer 03 Sep 2024 12,300 237,300 (0%) 0% 40.1 493,408 Common Stock
Badreddin Edris Chief Operating Officer 03 Sep 2024 3,080 229,600 (0%) 0% 42.1 129,591 Common Stock
James Cassidy Chief Medical Officer 30 Aug 2024 1,969 73,856 (0%) 0% 41.7 82,127 Common Stock
Martin W. Mackay Director 29 Jul 2024 29,445 29,445 - - Stock Option (Right to Buy)
Martin W. Mackay Director 29 Jul 2024 9,963 9,963 (0%) 0% 0 Common Stock
James Cassidy Chief Medical Officer 01 Jul 2024 591 75,825 (0%) 0% 38.5 22,771 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Jun 2024 33,240 1,128,128 (2%) 0% 39.4 1,309,666 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Jun 2024 400 1,112,368 (2%) 0% 42.1 16,837 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Jun 2024 6,600 1,112,768 (2%) 0% 41.4 273,247 Common Stock
Saqib Islam Director, Chief Executive Officer 03 Jun 2024 8,760 1,119,368 (2%) 0% 40.6 355,363 Common Stock
Julie Hambleton Director 03 Jun 2024 2,946 5,797 (0%) 0% 39.4 116,111 Common Stock
Julie Hambleton Director 03 Jun 2024 751 5,046 (0%) 0% 40.6 30,465 Common Stock
Julie Hambleton Director 03 Jun 2024 931 4,115 (0%) 0% 41.5 38,629 Common Stock
Julie Hambleton Director 03 Jun 2024 20 4,095 (0%) 0% 42.1 842 Common Stock
Badreddin Edris Chief Operating Officer 03 Jun 2024 4,192 253,636 (0%) 0% 40.6 170,287 Common Stock
Badreddin Edris Chief Operating Officer 03 Jun 2024 385 249,600 (0%) 0% 42.0 16,184 Common Stock
Badreddin Edris Chief Operating Officer 03 Jun 2024 3,651 249,985 (0%) 0% 41.4 151,066 Common Stock
Badreddin Edris Chief Operating Officer 03 Jun 2024 11,772 257,828 (0%) 0% 39.4 463,834 Common Stock
Freda C. Lewis-Hall Director 16 May 2024 12,216 12,216 - - Stock Option (Right to Buy)
Freda C. Lewis-Hall Director 16 May 2024 4,095 14,667 (0%) 0% 0 Common Stock
Alan Fuhrman Director 16 May 2024 4,095 14,667 (0%) 0% 0 Common Stock
Alan Fuhrman Director 16 May 2024 12,216 12,216 - - Stock Option (Right to Buy)
Carlos Alban Director 16 May 2024 12,216 12,216 - - Stock Option (Right to Buy)
Carlos Alban Director 16 May 2024 4,095 18,801 (0%) 0% 0 Common Stock
Daniel S. Lynch Director 16 May 2024 4,095 305,944 (0%) 0% 0 Common Stock
Daniel S. Lynch Director 16 May 2024 12,216 12,216 - - Stock Option (Right to Buy)
Julie Hambleton Director 16 May 2024 4,095 8,743 (0%) 0% 0 Common Stock
Julie Hambleton Director 16 May 2024 12,216 12,216 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 01 Apr 2024 1,824 56,330 (0%) 0% 47.6 86,859 Common Stock
Daniel Pichl Chief People Officer 16 Feb 2024 15,000 45,212 (0%) 0% 50.1 751,550 Common Stock
Daniel Pichl Chief People Officer 16 Feb 2024 15,000 45,000 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 16 Feb 2024 15,000 60,212 (0%) 0% 27.6 414,600 Common Stock
Bhavesh Ashar Chief Commercial Officer 02 Feb 2024 1,089 65,121 (0%) 0% 43.7 47,640 Common Stock
Pichl Daniel Chief People Officer 02 Feb 2024 1,997 45,955 (0%) 0% 45.9 91,756 Common Stock
Pichl Daniel Chief People Officer 02 Feb 2024 743 45,212 (0%) 0% 46.4 34,507 Common Stock
Daniel Pichl Chief People Officer 02 Feb 2024 16,250 48,750 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 02 Feb 2024 1,667 63,454 (0%) 0% 44.3 73,868 Common Stock
Daniel Pichl Chief People Officer 02 Feb 2024 9,266 62,127 (0%) 0% 43.8 405,942 Common Stock
Daniel Pichl Chief People Officer 02 Feb 2024 16,250 71,393 (0%) 0% 27.6 449,150 Common Stock
Daniel Pichl Chief People Officer 02 Feb 2024 14,175 47,952 (0%) 0% 44.3 628,157 Common Stock
Bhavesh Ashar Chief Commercial Officer 02 Feb 2024 88 62,988 (0%) 0% 46.4 4,081 Common Stock
Ashar Bhavesh Chief Commercial Officer 02 Feb 2024 4,834 58,154 (0%) 0% 49.3 238,435 Common Stock
Ashar Bhavesh Chief Commercial Officer 02 Feb 2024 378 63,076 (0%) 0% 46.0 17,387 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2024 80,000 80,000 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 14,104 30,959 (0%) 0% 0 Common Stock
Weinstein Herschel S. General Counsel & Secretary 04 Jan 2024 2,423 52,239 (0%) 0% 41.5 100,627 Common Stock
Ashar Bhavesh Chief Commercial Officer 04 Jan 2024 75,000 75,000 - - Stock Option (Right to Buy)
Islam Saqib Director, Chief Executive Officer 04 Jan 2024 88,000 287,053 (0%) 0% 0 Common Stock
Tai-An Lin Chief Scientific Officer 04 Jan 2024 5,289 29,289 (0%) 0% 0 Common Stock
Cassidy James Chief Medical Officer 04 Jan 2024 2,357 77,509 (0%) 0% 38.0 89,472 Common Stock
Herschel S. Weinstein General Counsel & Secretary 04 Jan 2024 2,324 54,662 (0%) 0% 38.0 88,219 Common Stock
Bhavesh Ashar Chief Commercial Officer 04 Jan 2024 1,449 66,210 (0%) 0% 41.5 60,177 Common Stock
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 40,000 40,000 - - Stock Option (Right to Buy)
S. Weinstein Herschel General Counsel & Secretary 04 Jan 2024 21,156 56,986 (0%) 0% 0 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2024 1,093 76,416 (0%) 0% 41.5 45,392 Common Stock
Badreddin Edris Chief Operating Officer 04 Jan 2024 5,466 269,600 (0%) 0% 41.5 227,003 Common Stock
Smith L. Mary Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.53 per share. 04 Jan 2024 3,535 233,363 (0%) 0% 41.5 146,809 Common Stock
Islam Saqib Director, Chief Executive Officer 04 Jan 2024 12,885 274,168 (0%) 0% 38.0 489,115 Common Stock
Saqib Islam Director, Chief Executive Officer 04 Jan 2024 17,904 256,264 (0%) 0% 41.5 743,553 Common Stock
Francis Perier I. Chief Financial Officer 04 Jan 2024 2,151 62,468 (0%) 0% 38.0 81,652 Common Stock
S. Herschel Weinstein General Counsel & Secretary 04 Jan 2024 60,000 60,000 - - Stock Option (Right to Buy)
I. Francis Perier Chief Financial Officer 04 Jan 2024 21,156 64,619 (0%) 0% 0 Common Stock
Pichl Daniel Chief People Officer 04 Jan 2024 1,574 56,548 (0%) 0% 38.0 59,749 Common Stock
James Cassidy Chief Medical Officer 04 Jan 2024 28,208 79,866 (0%) 0% 0 Common Stock
Islam Saqib Director, Chief Executive Officer 04 Jan 2024 250,000 250,000 - - Stock Option (Right to Buy)
Pichl Daniel Chief People Officer 04 Jan 2024 22,919 58,122 (0%) 0% 0 Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 21,156 239,095 (0%) 0% 0 Common Stock
Francis I. Perier Chief Financial Officer 04 Jan 2024 3,215 59,253 (0%) 0% 41.5 133,519 Common Stock
Nofi Michael Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.53 per share. 04 Jan 2024 1,063 28,727 (0%) 0% 41.5 44,146 Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 60,000 60,000 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer 04 Jan 2024 42,312 279,535 (0%) 0% 0 Common Stock
Daniel Pichl Chief People Officer 04 Jan 2024 65,000 65,000 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer 04 Jan 2024 4,469 275,066 (0%) 0% 38.0 169,643 Common Stock
Ashar Bhavesh Chief Commercial Officer 04 Jan 2024 26,445 70,166 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 04 Jan 2024 120,000 120,000 - - Stock Option (Right to Buy)
I. Francis Perier Chief Financial Officer 04 Jan 2024 60,000 60,000 - - Stock Option (Right to Buy)
Smith L. Mary Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.96 per share. 04 Jan 2024 2,197 236,898 (0%) 0% 38.0 83,398 Common Stock
Daniel Pichl Chief People Officer 04 Jan 2024 1,405 55,143 (0%) 0% 41.5 58,350 Common Stock
Nofi Michael Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.96 per share. 04 Jan 2024 1,169 29,790 (0%) 0% 38.0 44,375 Common Stock
Bhavesh Ashar Chief Commercial Officer 04 Jan 2024 2,507 67,659 (0%) 0% 38.0 95,166 Common Stock
Lin Tai-An Chief Scientific Officer 04 Jan 2024 15,000 15,000 - - Stock Option (Right to Buy)
Julie Hambleton Director 19 Jul 2023 2,418 4,648 (0%) 0% 29.3 70,876 Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 5,720 217,939 (0%) 0% - Common Stock
James Cassidy Chief Medical Officer 30 Jun 2023 5,720 52,950 (0%) 0% - Common Stock
Julie Hambleton Director 20 Jun 2023 2,400 7,066 (0%) 0% 26.9 64,603 Common Stock
Freda C. Lewis-Hall Director 24 May 2023 4,648 10,572 (0%) 0% 0 Common Stock
Freda C. Lewis-Hall Director 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Alan Fuhrman Director 24 May 2023 4,648 10,572 (0%) 0% 0 Common Stock
Alan Fuhrman Director 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Carlos Alban Director 24 May 2023 4,648 14,706 (0%) 0% 0 Common Stock
Carlos Alban Director 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Daniel S. Lynch Director 24 May 2023 4,648 301,849 (0%) 0% 0 Common Stock
Daniel S. Lynch Director 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Julie Hambleton Director 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Julie Hambleton Director 24 May 2023 4,648 9,466 (0%) 0% 0 Common Stock
Jeffrey Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 13,774 13,774 - - Stock Option (Right to Buy)
Jeffrey Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 4,648 10,572 (0%) 0% 0 Common Stock
Bhavesh Ashar Chief Commercial Officer 03 Apr 2023 1,375 43,721 (0%) 0% 25.3 34,719 Common Stock
Jeffrey Schwartz Director Sale of securities on an exchange or to another person at price $ 28.50 per share. 16 Mar 2023 1,750,000 3,081,307 (7%) 4% 28.5 49,875,000 Common Stock
Julie Hambleton Director 15 Mar 2023 1,106 4,818 (0%) 0% 31.5 34,841 Common Stock
Daniel Pichl Chief People Officer 26 Jan 2023 858 35,203 (0%) 0% 31 26,598 Common Stock
Herschel S. Weinstein General Counsel & Secretary 07 Jan 2023 909 35,830 (0%) 0% 26.4 24,007 Common Stock
Francis I. Perier Chief Financial Officer 07 Jan 2023 1,090 43,463 (0%) 0% 26.4 28,787 Common Stock
Saqib Islam Director, Chief Executive Officer 07 Jan 2023 4,097 905,104 (2%) 0% 26.4 108,202 Common Stock
Michael Nofi Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.41 per share. 07 Jan 2023 409 16,855 (0%) 0% 26.4 10,802 Common Stock
L. Mary Smith Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.41 per share. 07 Jan 2023 1,068 212,219 (0%) 0% 26.4 28,206 Common Stock
Daniel Pichl Chief People Officer 07 Jan 2023 546 36,061 (0%) 0% 26.4 14,420 Common Stock
Herschel S. Weinstein General Counsel & Secretary 05 Jan 2023 19,425 38,521 (0%) 0% - Common Stock
Herschel S. Weinstein General Counsel & Secretary 05 Jan 2023 1,782 36,739 (0%) 0% 27.5 49,041 Common Stock
Herschel S. Weinstein General Counsel & Secretary 05 Jan 2023 60,000 60,000 - - Stock Option (Right to Buy)
Herschel S. Weinstein General Counsel & Secretary 05 Jan 2023 65,000 65,000 - - Stock Option (Right to Buy)
Francis I. Perier Chief Financial Officer 05 Jan 2023 65,000 65,000 - - Stock Option (Right to Buy)
Francis I. Perier Chief Financial Officer 05 Jan 2023 60,000 60,000 - - Stock Option (Right to Buy)
Francis I. Perier Chief Financial Officer 05 Jan 2023 2,374 44,553 (0%) 0% 27.5 65,332 Common Stock
Francis I. Perier Chief Financial Officer 05 Jan 2023 19,425 46,927 (0%) 0% - Common Stock
Saqib Islam Director, Chief Executive Officer 05 Jan 2023 84,175 917,601 (2%) 0% - Common Stock
Saqib Islam Director, Chief Executive Officer 05 Jan 2023 8,400 909,201 (2%) 0% 27.5 231,168 Common Stock
Saqib Islam Director, Chief Executive Officer 05 Jan 2023 260,000 260,000 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 30,000 30,000 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 9,713 18,047 (0%) 0% - Common Stock
Michael Nofi Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.52 per share. 05 Jan 2023 783 17,264 (0%) 0% 27.5 21,548 Common Stock
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 35,000 35,000 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer 05 Jan 2023 135,000 135,000 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer 05 Jan 2023 33,994 242,032 (0%) 0% - Common Stock
Badreddin Edris Chief Operating Officer 05 Jan 2023 3,326 238,706 (0%) 0% 27.5 91,532 Common Stock
Badreddin Edris Chief Operating Officer 05 Jan 2023 105,000 105,000 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 65,000 65,000 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 70,000 70,000 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.52 per share. 05 Jan 2023 2,452 213,287 (0%) 0% 27.5 67,479 Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 22,663 215,739 (0%) 0% - Common Stock
Daniel Pichl Chief People Officer 05 Jan 2023 1,719 36,607 (0%) 0% 27.5 47,307 Common Stock
Daniel Pichl Chief People Officer 05 Jan 2023 19,425 38,326 (0%) 0% - Common Stock
Daniel Pichl Chief People Officer 05 Jan 2023 65,000 65,000 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 05 Jan 2023 60,000 60,000 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 05 Jan 2023 1,665 45,096 (0%) 0% 27.5 45,821 Common Stock
Bhavesh Ashar Chief Commercial Officer 05 Jan 2023 22,663 46,761 (0%) 0% - Common Stock
Bhavesh Ashar Chief Commercial Officer 05 Jan 2023 70,000 70,000 - - Stock Option (Right to Buy)
James Cassidy Chief Medical Officer 05 Jan 2023 70,000 70,000 - - Stock Option (Right to Buy)
James Cassidy Chief Medical Officer 05 Jan 2023 1,263 47,230 (0%) 0% 27.5 34,758 Common Stock
James Cassidy Chief Medical Officer 05 Jan 2023 65,000 65,000 - - Stock Option (Right to Buy)
James Cassidy Chief Medical Officer 05 Jan 2023 22,663 48,493 (0%) 0% - Common Stock
L. Mary Smith Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.47 per share. 18 Jul 2022 1,551 193,076 (0%) 0% 28.5 44,157 Common Stock
Michael Burgess Head of Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.47 per share. 18 Jul 2022 3,103 49,584 (0%) 0% 28.5 88,342 Common Stock
Carlos Alban Director 14 Jul 2022 10,058 10,058 (0%) 0% 0 Common Stock
Carlos Alban Director 14 Jul 2022 30,160 30,160 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 6,092 194,627 (0%) 0% 0 Common Stock
Michael Burgess Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 12,185 52,687 (0%) 0% 0 Common Stock
Michael Burgess Head of Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. 01 Jun 2022 2,672 40,502 (0%) 0% 19.6 52,398 Common Stock
Freda C. Lewis-Hall Director 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Freda C. Lewis-Hall Director 19 May 2022 4,818 5,924 (0%) 0% 0 Common Stock
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 4,818 131,652 (0%) 0% 0 Common Stock
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Alan Fuhrman Director 19 May 2022 4,818 5,924 (0%) 0% 0 Common Stock
Alan Fuhrman Director 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Daniel S. Lynch Director 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Daniel S. Lynch Director 19 May 2022 4,818 297,201 (0%) 0% 0 Common Stock
Julie Hambleton Director 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Julie Hambleton Director 19 May 2022 4,818 5,924 (0%) 0% 0 Common Stock
Jeffrey Schwartz, Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 15,318 15,318 - - Stock Option (Right to Buy)
Jeffrey Schwartz, Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 4,818 5,924 (0%) 0% 0 Common Stock
Bhavesh Ashar Chief Commercial Officer 01 Apr 2022 100,000 100,000 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 01 Apr 2022 1,464 24,098 (0%) 0% 56.9 83,302 Common Stock
Herschel S. Weinstein General Counsel & Secretary 07 Jan 2022 966 19,096 (0%) 0% 56.1 54,154 Common Stock
Francis I. Perier Chief Financial Officer 07 Jan 2022 1,307 27,502 (0%) 0% 56.1 73,270 Common Stock
Saqib Islam Director, Chief Executive Officer 07 Jan 2022 3,996 853,592 (1%) 0% 56.1 224,016 Common Stock
Michael Nofi Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.06 per share. 07 Jan 2022 414 8,334 (0%) 0% 56.1 23,209 Common Stock
Badreddin Edris Chief Operating Officer 07 Jan 2022 1,852 325,813 (0%) 0% 56.1 103,823 Common Stock
Badreddin Edris Chief Operating Officer 07 Jan 2022 1,483 237,223 (0%) 0% 26.4 39,166 Common Stock
L. Mary Smith Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.06 per share. 07 Jan 2022 1,181 188,535 (0%) 0% 56.1 66,207 Common Stock
Daniel Pichl Chief People Officer 07 Jan 2022 631 21,667 (0%) 0% 56.1 35,374 Common Stock
Herschel S. Weinstein General Counsel & Secretary 06 Jan 2022 40,710 40,710 - - Stock Option (Right to Buy)
Herschel S. Weinstein General Counsel & Secretary 06 Jan 2022 13,062 20,062 (0%) 0% - Common Stock
Francis I. Perier Chief Financial Officer 06 Jan 2022 18,809 28,809 (0%) 0% - Common Stock
Francis I. Perier Chief Financial Officer 06 Jan 2022 58,622 58,622 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer 06 Jan 2022 244,258 244,258 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer 06 Jan 2022 78,370 857,588 (1%) 0% - Common Stock
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 17,913 17,913 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 5,748 8,748 (0%) 0% - Common Stock
Badreddin Edris Chief Operating Officer 06 Jan 2022 26,124 327,665 (0%) 0% - Common Stock
Badreddin Edris Chief Operating Officer 06 Jan 2022 81,420 81,420 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 22,205 189,716 (0%) 0% - Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 69,207 69,207 - - Stock Option (Right to Buy)
Michael Burgess Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 48,852 48,852 - - Stock Option (Right to Buy)
Michael Burgess Head of Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 15,674 43,174 (0%) 0% - Common Stock
Daniel Pichl Chief People Officer 06 Jan 2022 13,062 22,298 (0%) 0% - Common Stock
Daniel Pichl Chief People Officer 06 Jan 2022 40,710 40,710 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 06 Jan 2022 40,710 40,710 - - Stock Option (Right to Buy)
Bhavesh Ashar Chief Commercial Officer 06 Jan 2022 13,062 25,562 (0%) 0% - Common Stock
Saqib Islam Director, Chief Executive Officer 20 Oct 2021 10,083 779,218 (1%) 0% 58.7 591,527 Common Stock
Saqib Islam Director, Chief Executive Officer 18 Oct 2021 14,077 769,135 (1%) 0% 58.8 827,873 Common Stock
Saqib Islam Director, Chief Executive Officer 18 Oct 2021 38,340 783,212 (1%) 0% 58.6 2,246,505 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. 13 Oct 2021 10,000 177,511 (0%) 0% 2.3 23,000 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Oct 2021 10,000 84,296 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Sale of securities on an exchange or to another person at price $ 55.97 per share. 13 Oct 2021 10,000 167,511 (0%) 0% 56.0 559,675 Common Stock
Daniel Pichl Chief People Officer 08 Sep 2021 2,320 72,680 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 08 Sep 2021 2,320 9,236 (0%) 0% 43.1 99,992 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Jul 2021 18,572 821,552 (1%) 0% 77.7 1,442,751 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Jul 2021 43,928 840,124 (1%) 0% 76.1 3,342,438 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. 13 Jul 2021 10,000 177,511 (0%) 0% 2.3 23,000 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jul 2021 10,000 94,296 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Sale of securities on an exchange or to another person at price $ 80.88 per share. 13 Jul 2021 10,000 167,511 (0%) 0% 80.9 808,777 Common Stock
Badreddin Edris Chief Operating Officer 01 Jul 2021 32,000 301,541 (0%) 0% 85.3 2,731,088 Common Stock
Freda C. Lewis-Hall Director 20 May 2021 1,106 25,227 (0%) 0% 0 Common Stock
Freda C. Lewis-Hall Director 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 1,106 126,834 (0%) 0% 0 Common Stock
Alan Fuhrman Director 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Alan Fuhrman Director 20 May 2021 1,106 25,227 (0%) 0% 0 Common Stock
Daniel S. Lynch Director 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Daniel S. Lynch Director 20 May 2021 1,106 292,383 (0%) 0% 0 Common Stock
Julie Hambleton Director 20 May 2021 1,106 5,995 (0%) 0% 0 Common Stock
Julie Hambleton Director 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Jeffrey Schwartz, Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 1,106 1,106 (0%) 0% 0 Common Stock
Jeffrey Schwartz, Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 6,998 6,998 - - Stock Option (Right to Buy)
Stephen P. Squinto Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 76.20 per share. 27 Apr 2021 19,231 125,728 (0%) 0% 76.2 1,465,437 Common Stock
Stephen P. Squinto Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 75.05 per share. 27 Apr 2021 201 144,959 (0%) 0% 75.0 15,085 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Apr 2021 38,425 908,127 (2%) 0% 69.0 2,652,827 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Apr 2021 24,075 884,052 (2%) 0% 66.4 1,598,279 Common Stock
Stephen P. Squinto Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 75.02 per share. 14 Apr 2021 1,057 145,160 (0%) 0% 75.0 79,291 Common Stock
Stephen P. Squinto Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 75.08 per share. 14 Apr 2021 511 146,217 (0%) 0% 75.1 38,365 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. 13 Apr 2021 10,000 177,511 (0%) 0% 2.3 23,000 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2021 10,000 104,296 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Sale of securities on an exchange or to another person at price $ 68.07 per share. 13 Apr 2021 10,000 167,511 (0%) 0% 68.1 680,723 Common Stock
Bhavesh Ashar Chief Commercial Officer 01 Apr 2021 12,500 12,500 (0%) 0% 0 Common Stock
Bhavesh Ashar Chief Commercial Officer 01 Apr 2021 92,000 92,000 - - Stock Option (Right to Buy)
Badreddin Edris Chief Operating Officer 25 Jan 2021 32,000 261,542 (0%) 0% 84.1 2,690,282 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. 20 Jan 2021 8,872 177,511 (0%) 0% 2.3 20,406 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2021 8,872 114,296 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jan 2021 1,128 1,451 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.70 per share. 20 Jan 2021 10,000 167,511 (0%) 0% 78.7 787,016 Common Stock
L. Mary Smith Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.65 per share. 20 Jan 2021 1,128 168,639 (0%) 0% 1.6 1,861 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Jan 2021 2,199 1,222,997 (2%) 0% 78.8 173,180 Common Stock
Saqib Islam Director, Chief Executive Officer 19 Jan 2021 60,301 1,225,196 (2%) 0% 78.5 4,736,209 Common Stock
Herschel S. Weinstein General Counsel and Secretary 07 Jan 2021 56,000 56,000 - - Stock Option (Right to Buy)
Herschel S. Weinstein General Counsel and Secretary 07 Jan 2021 7,000 7,000 (0%) 0% 0 Common Stock
Francis I. Perier Chief Financial Officer 07 Jan 2021 10,000 10,000 (0%) 0% 0 Common Stock
Francis I. Perier Chief Financial Officer 07 Jan 2021 80,000 80,000 - - Stock Option (Right to Buy)
Saqib Islam Director, Chief Executive Officer 07 Jan 2021 37,500 1,285,497 (2%) 0% 0 Common Stock
Saqib Islam Director, Chief Executive Officer 07 Jan 2021 300,000 300,000 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 24,000 24,000 - - Stock Option (Right to Buy)
Michael Nofi Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 3,000 3,000 (0%) 0% 0 Common Stock
Jens Renstrup Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 48,600 48,600 - - Stock Option (Right to Buy)
Jens Renstrup Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 6,075 250,499 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 07 Jan 2021 13,000 293,542 (0%) 0% 0 Common Stock
Badreddin Edris Chief Operating Officer 07 Jan 2021 104,000 104,000 - - Stock Option (Right to Buy)
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 11,000 167,511 (0%) 0% 0 Common Stock
L. Mary Smith Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 88,000 88,000 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 07 Jan 2021 4,150 4,150 (0%) 0% 0 Common Stock
Daniel Pichl Chief People Officer 07 Jan 2021 33,200 33,200 - - Stock Option (Right to Buy)
Daniel Pichl Chief People Officer 03 Aug 2020 75,000 75,000 - - Stock Option (Right to Buy)
Freda C. Lewis-Hall Director, Ten Percent Owner 20 May 2020 7,464 7,464 - - Stock Option (Right to Buy)
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 7,464 7,464 - - Stock Option (Right to Buy)
Alan Fuhrman None 20 May 2020 7,464 7,464 - - Stock Option (Right to Buy)
Daniel S. Lynch Director, Ten Percent Owner 20 May 2020 7,464 7,464 - - Stock Option (Right to Buy)
Julie Hambleton None 20 May 2020 14,668 14,668 - - Stock Option (Right to Buy)
Jeffrey Schwartz, Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 7,464 7,464 - - Stock Option (Right to Buy)
Stephen P. Squinto Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 20,000 20,000 - - Common Stock
Herschel S. Weinstein General Counsel and Secretary 03 Feb 2020 106,600 106,600 - - Stock Option (Right to Buy)
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 526,602 0 - - Series B Convertible Preferred Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 3,039,051 0 - - Series A Convertible Preferred Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 978,194 978,194 (2%) 2% 0 Common Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 3,039,051 4,017,245 (9%) 7% 0 Common Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 526,602 4,543,847 (10%) 1% 0 Common Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 978,194 0 - - Junior Series A Convertible Preferred Stock
Freda C. Lewis-Hall Director, Ten Percent Owner 17 Sep 2019 50,000 4,593,847 (10%) 0% 18 900,000 Common Stock
Stephen P. Squinto Director, Ten Percent Owner 17 Sep 2019 6,078,103 6,078,103 (14%) 14% 0 Common Stock
Stephen P. Squinto Director, Ten Percent Owner 17 Sep 2019 1,053,204 0 - - Series B Convertible Preferred Stock
Stephen P. Squinto Director, Ten Percent Owner 17 Sep 2019 6,078,103 0 - - Series A Convertible Preferred Stock
Stephen P. Squinto Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 17 Sep 2019 275,000 7,406,307 (17%) 0% 18 4,950,000 Common Stock
Stephen P. Squinto Director, Ten Percent Owner 17 Sep 2019 1,053,204 7,131,307 (16%) 2% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters